Alliance Growers Corp. (CSE:ACG; FWB:1LA) has provided updates on equity facility negotiations and the company’s projects that will ultimately make Alliance a successful global cannabis company. Alliance continues to deliver on its strategy to build a global cannabis company that is positioned for where the cannabis market will be, not only where it is now.
$5 Million to $10 Million Equity Facility with Private Equity Firm
In addition to the current private placement, Alliance is currently negotiating terms on an equity facility to meet our capital requirements for the following projects.
Property Identified for Cannabis Botany Centre
BRIM and Alliance have identified a property for the 40,000 square foot Cannabis Botany Centre. It consists of 40 acres of land in Miracle Valley, east of Mission, with the potential to develop up to 1 million square feet of facility space. This property has zoning that is approved for Health Canada Licensed Producer facilities. Thanks to the tremendous potential in the Cannabis space, we now have multiple options to finance the purchase of the land and the construction of the facility.
Strategic Alliances and Investments in Licensed Producer Applicants
Through a serious of strategic alliances and investments in Licensed Producers at various stages in the license process, Alliance is focused on securing long term plantlet supply contracts for the Cannabis Botany Centre and off-take agreements at wholesale cost for flower to be used for cannabidiol (CBD) oil extraction. Alliance will announce later this week, the final terms on a 5% non-dilutive interest in a private company in Ontario that has assembled a top tier growing team with management that has the expertise to expedite the license producer application process.
Additional Licensed Producer Applicants have approached Alliance looking to partner with a public company and negotiations are ongoing.
Read the full company profile.
Permits Secured by Israeli Medical Cannabis Company
Further to the company’s commitment to become a leading supplier of pharmaceutical grade CBD oil on a global basis, Alliance continues discussions setting out terms for an equity investment and/or joint venture with an Israeli medical cannabis company.
Last week the Company was informed that all permits were in place on 45-50 hectares of land for the growth of high quality cannabis plants in an offshore, low operating cost jurisdiction. The Israeli medical cannabis company brings first-class technology for production and processing based on Israeli technology in addition to specific strains and processing knowhow. This would facilitate the importation of the CBD Oil into various states in the USA, into Canada when legalized, and into countries like Germany now that the laws have changed. We expect many more European countries to follow suit in the months to come.
The Hemp Business Journal reports that the CBD market is growing at a rate of 30% per annum, and forecasts that sales of CBD Oils from marijuana-based sources are expected to reach $1,650,000,000, or 79% of the total CBD Market of $2,100,000,000 by 2020. And this is in the USA only. Dennis Petke, President and CEO stated “We are very excited to for the opportunity to take advantage of the equity facility to execute on our business plan. The equity firm we are negotiating with has financed other well-known Canadian Cannabis companies in the past 2 years. Over time we expect new investors and our shareholders to begin to see that we are building a global cannabis company that stands out from other Canadian cannabis companies whose entire business is directly affected by Health Canada rules and regulations.”
Connect with Alliance Growers Corp. (CSE:ACG; FWB:1LA) to receive an Investor Presentation.

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less